We acknowledge that a variety of other biomarkers have been shown to be elevated in the serum of MS patients, including the adhesion molecule sICAM-1 (28), the matrix metalloproteinase MMP9 (29), and glial fibrillary acidic protein (30). Here, MMP9 is linked to myeloid sarcoma.